Lv6
2433 积分 2025-01-10 加入
Lorlatinib. ALK/ROS1 inhibitor, Treatment of non-small cell lung cancer
3个月前
已关闭
Suzuki–Miyaura (hetero-)aryl cross-coupling: recent findings and recommendations
5个月前
已完结
Sphingosine kinase 2 in cancer: A review of its expression, function, and inhibitor development
5个月前
已完结
Modular Synthesis of New Pyrroloquinoline Quinone Derivatives
7个月前
已完结
Asymmetric biomimetic aldol reaction of glycinate enables highly efficient synthesis of chiral β-hydroxy-α-amino acid derivatives
7个月前
已完结
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective Inhibitor
8个月前
已完结
Synthesis of 3,9-Dialkyl-1,8-cineole Derivatives Based on Diels–Alder Adducts of Levoglucosenone with Isoprene and Butadiene
8个月前
已完结
皖公网安备34019202002308
